Paolo Tarantino, 2025 Yvonne’s “Top Voice” Award Winner, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn about a paper he co-authored with colleagues, published in the Nature Review:
“Grateful for the chance to chair the ESMO25 ADC educational session and present on ADC toxicities.
With the use of ADCs rapidly expanding across cancers, it’s critical to be aware of how to identify, prevent and mitigate their side effects.
For an in-depth dive into the topic, read our Nature Review article.”
Title: Optimizing the safety of antibody–drug conjugates for patients with solid tumours
Authors: Paolo Tarantino, Biagio Ricciuti, Shan M. Pradhan, Sara M. Tolaney
Read the full article on Nature Review.
More posts featuring Paolo Tarantino on OncoDaily.
